Some musculo-skeletal sequelae in cancer survivors

被引:21
作者
Aksnes, Liv Hege [1 ]
Bruland, Oyvind Sverre
机构
[1] Norwegian Radium Hosp, Med Ctr, Rikshosp, Canc Clin, Oslo, Norway
[2] Univ Oslo, Dept Grp Clin Med, N-0316 Oslo, Norway
关键词
D O I
10.1080/02841860701218642
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper deals with some of the musculo-skeletal complication that can occur after cancer treatment. In particular, we focus on Cancer Treatment Induced Bone Loss (CTIBL) and the musculo-skeletal complications that can occur in patients treated for extremity sarcoma. In addition we discuss peripheral neuropathy, musculo-skeletal pain and briefly mention some of the complications related to radiotherapy. CTIBL is mostly studied in breast cancer and prostate cancer survivors. The cause in these groups is mainly due to treatment induced hypogonadism. Other causes of CTIBL are indirect or direct cause of chemotherapy, physical inactivity and inadequate intake of vitamin D and calcium. Treatment of CTIBL consists of diet and lifestyle changes and pharmacological intervention. Extremity bone sarcomas constitute a special group since they often experience mutilating surgery and heavy combination chemotherapy. The treatment results in worse function than the normal population and the amputated usually have lower physical functioning than patients treated with limb sparing surgery (LSS). However, most studies fail to show differences in quality of life between the amputated and LSS. Most of the studies performed on musculo- skeletal sequelae have been done on survivors of childhood cancer, breast cancer or prostate cancer. More studies among the other cancer groups are needed to reveal the extent and prevalence of these complications.
引用
收藏
页码:490 / 496
页数:7
相关论文
共 70 条
[1]   Management of high-grade bone sarcomas over two decades:: The Norwegian Radium Hospital experience [J].
Aksnes, LH ;
Hall, KS ;
Folleraas, G ;
Stenwig, AE ;
Bjerkehagen, B ;
Taksdal, I ;
Winderen, M ;
Bruland, OS ;
Sæter, G .
ACTA ONCOLOGICA, 2006, 45 (01) :38-46
[2]   Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli Osteosarcoma-2 protocol: An updated report [J].
Bacci, G ;
Ferrari, S ;
Bertoni, F ;
Ruggieri, P ;
Picci, P ;
Longhi, A ;
Casadei, R ;
Fabbri, N ;
Forni, C ;
Versari, M ;
Campanacci, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (24) :4016-4027
[3]   The diagnosis and treatment of osteoporosis in men on androgen deprivation therapy for advanced carcinoma of the prostate [J].
Bae, DC ;
Stein, BS .
JOURNAL OF UROLOGY, 2004, 172 (06) :2137-2144
[4]  
Ballo Matthew T, 2003, Surg Oncol Clin N Am, V12, P449, DOI 10.1016/S1055-3207(03)00008-5
[5]   Osteoporosis in children and adolescents etiology and management [J].
Baroncelli G.I. ;
Bertelloni S. ;
Sodini F. ;
Saggese G. .
Pediatric Drugs, 2005, 7 (5) :295-323
[6]   Osteopenia in children surviving brain tumours [J].
Barr, RD ;
Simpson, T ;
Webber, CE ;
Gill, GJ ;
Hay, J ;
Eves, M ;
Whitton, AC .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (06) :873-877
[7]   Glucorticoids and bone: Some general remarks and some special observations in pediatric patients [J].
Bianchi, ML .
CALCIFIED TISSUE INTERNATIONAL, 2002, 70 (05) :384-390
[9]  
BUTLER MS, 1990, CLIN ORTHOP RELAT R, V251, P235
[10]   Aromatase inhibitors and bone health in women with breast cancer [J].
Chien, Amy Jo ;
Goss, Paul E. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) :5305-5312